Page 5 - Molefi Phamotse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molefi phamotse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molefi Phamotse Today - Breaking & Trending Today

SAFA deny that Molefi Ntseki is Bafana Bafana's assistant coach


SAFA deny that Molefi Ntseki is Bafana Bafana s assistant coach
News24
15 May 2021, 08:10 GMT+10
Molefi Ntseki was the subject of a bizarre turn of events on Friday after he was named by
Bafana Bafana head coach
Hugo Broos as part of a new-look technical team, a claim that has since been denied by
SAFA.
The Belgian named his predecessor Ntseki - who SAFA recently sacked - as his assistant during an interview on the Sport On with Thabiso Mosia show on SAfm.
SAFA released a statement that contradicted their own head coach by dismissing earlier reports while insisting a local assistant coach was yet to be finalised. ....

South Africa , South African , Hugo Broos , Thabiso Mosia , Molefi Ntseki , Chedomir Janevski , Cup Qualifier , Weird News , Molefi Ntseki , Bafana Bafana , கோப்பை தகுதி , வித்தியாசமானது செய்தி ,

Celyad Oncology SA: Celyad: Transparency Notification Received From Tolefi SA (Article 14 §1 of the Law of 2 May 2007)


(0)
Regulatory News:
Celyad Oncology SA (Euronext Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that it has received a transparency notification from Tolefi SA, dated 3 May 2021.
Tolefi SA has notified that its 2.295.701 shares benefit from a double voting right as of May 3, 2021 and that its shareholding has crossed above the threshold of 25%. The full transparency notice is available on the Celyad website under the heading Regulated Information .
About Celyad Oncology SA
Celyad Oncology SA is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of bot ....

Mont Saint Guibert , Waals Gewest , New York , United States , Walloon Region , France General , Bruxelles Capitale , Sara Zelkovic , Exchange Commission , Communications Investor Relations , Lifesci Advisors , Regulatory News , Euronext Nasdaq , Private Securities Litigation Reform Act , Celyad Oncology , Annual Report , Media Contacts , Investor Relations Director , Sci Advisors , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சுவர் பகுதி , பிரான்ஸ் ஜநரல் , ப்ரூக்ஸெல்ஸ் தலைநகரம் , பரிமாற்றம் தரகு , தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் ,